August 10, 2017 / 8:50 PM / 9 days ago

BRIEF-FDA accepts Achieve's IND for its smoking cessation drug

Aug 10 (Reuters) - Achieve Life Sciences Inc-

* Achieve announces FDA acceptance of the investigational new drug application (IND) for cytisine as a smoking cessation treatment

* Achieve Life Sciences Inc- ‍achieve expects to commence a phase 3 trial of cytisine in united states in first-half of 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below